Bioscience
Cenna Biosciences, based in La Jolla, California, is a biopharmaceutical company dedicated to developing innovative treatments for Alzheimer's disease. Their lead product, Nubytide, is a potential disease-modifying peptide designed to prevent and treat Alzheimer's by inhibiting the production of amyloid-beta, a key factor in the disease's progression.
The company aims to make Nubytide accessible to all patients over the age of 65, offering a proactive therapy that is affordable and easy to administer. With a strong intellectual property position and significant market potential, Cenna Biosciences is poised to advance Nubytide through clinical development, addressing the urgent need for effective Alzheimer's treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.